DK0579222T3 - Fedtstofskifteforbedrende middel - Google Patents
Fedtstofskifteforbedrende middelInfo
- Publication number
- DK0579222T3 DK0579222T3 DK93111331.0T DK93111331T DK0579222T3 DK 0579222 T3 DK0579222 T3 DK 0579222T3 DK 93111331 T DK93111331 T DK 93111331T DK 0579222 T3 DK0579222 T3 DK 0579222T3
- Authority
- DK
- Denmark
- Prior art keywords
- diseases
- compound
- group
- infarction
- cerebral
- Prior art date
Links
- 239000003623 enhancer Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract 1
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract 1
- 206010029164 Nephrotic syndrome Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000007574 infarction Effects 0.000 abstract 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 abstract 1
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000009928 nephrosis Diseases 0.000 abstract 1
- 231100001027 nephrosis Toxicity 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19074892 | 1992-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0579222T3 true DK0579222T3 (da) | 1996-04-09 |
Family
ID=16263093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93111331.0T DK0579222T3 (da) | 1992-07-17 | 1993-07-15 | Fedtstofskifteforbedrende middel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5378692A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0579222B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JPH0680582A (cg-RX-API-DMAC10.html) |
| KR (1) | KR100205264B1 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE131046T1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2099346A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE69300945T2 (cg-RX-API-DMAC10.html) |
| DK (1) | DK0579222T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2080564T3 (cg-RX-API-DMAC10.html) |
| GR (1) | GR3018325T3 (cg-RX-API-DMAC10.html) |
| TW (1) | TW225992B (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0469156B1 (en) * | 1990-02-17 | 1996-10-23 | Senju Pharmaceutical Co., Ltd. | Glutathione derivative |
| TW252918B (cg-RX-API-DMAC10.html) * | 1993-03-31 | 1995-08-01 | Senju Pharma Co | |
| TW401301B (en) * | 1994-10-07 | 2000-08-11 | Takeda Chemical Industries Ltd | Antihypertriglyceridemic composition |
| DE102005022845A1 (de) * | 2005-05-18 | 2006-11-23 | Fumapharm Ag | Thiobernsteinsäurederivate und deren Verwendung |
| JP5356174B2 (ja) * | 2009-10-02 | 2013-12-04 | 日本メナード化粧品株式会社 | Ｓ−ラクトイルグルタチオン及び／又はその塩を含有することを特徴とする医薬組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2187327B1 (cg-RX-API-DMAC10.html) * | 1972-06-15 | 1975-06-20 | Rech Pharm Scientifiques | |
| DE3722647A1 (de) * | 1987-07-09 | 1989-01-19 | Gerhard Ohlenschlaeger | Galenische verwendung eines tripeptids als arzneimittel |
| JPH02255624A (ja) * | 1989-03-29 | 1990-10-16 | Senjiyu Seiyaku Kk | 血小板凝集抑制剤 |
| JP2815179B2 (ja) * | 1989-07-14 | 1998-10-27 | 千寿製薬株式会社 | 抗炎症および／または抗アレルギー剤 |
| JP2919870B2 (ja) * | 1989-09-29 | 1999-07-19 | 千寿製薬株式会社 | 肝障害抑制剤 |
| EP0469156B1 (en) * | 1990-02-17 | 1996-10-23 | Senju Pharmaceutical Co., Ltd. | Glutathione derivative |
| WO1991015204A2 (en) * | 1990-04-09 | 1991-10-17 | The Rockefeller University | METHOD AND AGENTS FOR THE SELECTIVE REDUCTION OF Lp(a) |
| DE69123428T2 (de) * | 1990-04-26 | 1997-05-15 | Senju Pharma Co | Inhibitor von lebererkrankungen |
| US5212159A (en) * | 1991-02-27 | 1993-05-18 | Senju Pharmaceutical Co., Ltd. | Anticataract composition |
-
1993
- 1993-06-28 TW TW082105114A patent/TW225992B/zh active
- 1993-06-28 CA CA002099346A patent/CA2099346A1/en not_active Abandoned
- 1993-07-06 US US08/085,875 patent/US5378692A/en not_active Expired - Fee Related
- 1993-07-12 JP JP5171370A patent/JPH0680582A/ja active Pending
- 1993-07-15 EP EP93111331A patent/EP0579222B1/en not_active Expired - Lifetime
- 1993-07-15 AT AT93111331T patent/ATE131046T1/de not_active IP Right Cessation
- 1993-07-15 DK DK93111331.0T patent/DK0579222T3/da active
- 1993-07-15 ES ES93111331T patent/ES2080564T3/es not_active Expired - Lifetime
- 1993-07-15 DE DE69300945T patent/DE69300945T2/de not_active Expired - Fee Related
- 1993-07-16 KR KR1019930013493A patent/KR100205264B1/ko not_active Expired - Fee Related
-
1995
- 1995-12-07 GR GR950403386T patent/GR3018325T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE131046T1 (de) | 1995-12-15 |
| DE69300945T2 (de) | 1996-04-25 |
| KR100205264B1 (ko) | 1999-07-01 |
| KR940001901A (ko) | 1994-02-16 |
| EP0579222A2 (en) | 1994-01-19 |
| TW225992B (cg-RX-API-DMAC10.html) | 1994-07-01 |
| EP0579222B1 (en) | 1995-12-06 |
| GR3018325T3 (en) | 1996-03-31 |
| ES2080564T3 (es) | 1996-02-01 |
| DE69300945D1 (de) | 1996-01-18 |
| CA2099346A1 (en) | 1994-01-18 |
| EP0579222A3 (en) | 1994-05-18 |
| US5378692A (en) | 1995-01-03 |
| JPH0680582A (ja) | 1994-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR970701722A (ko) | 포스폰산 디에스테르 유도체(phosphonic diester derivative) | |
| CA2207835A1 (fr) | Nouveaux derives du 3-(piperid-4-yl) 1,2-benzisoxazole et du 3-(piperazin-4-yl) 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| TW252918B (cg-RX-API-DMAC10.html) | ||
| DE69320952D1 (de) | Verwendung von terfenadin-derivaten als antihistaminika in leberkranken patienten | |
| DE60025616D1 (de) | Isoindolderivate | |
| ID24846A (id) | Turunan-turunan bifenilamidina | |
| CA2332513A1 (fr) | Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| TR199902350T2 (xx) | Yeni piridin t�revleri ve onlardan olu�an farmakotik bile�imler. | |
| ATE131046T1 (de) | Fettstoffwechsel verbessernde zusammensetzung. | |
| ATE86866T1 (de) | Antikrebs-zusammensetzung. | |
| WO2001044207B1 (fr) | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant | |
| IL85768A (en) | Benzoxazine derivatives, their preparation and pharmaceutical compositions containing them | |
| KR970703301A (ko) | 신규 디아미노메틸리덴 유도체(novel diamincmethylidene derivative) | |
| GR3036029T3 (en) | Optically active thiazolidinone derivatives | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| DE69129790D1 (de) | 5-Amino-5,6,7,8-Tetrahydrochinoline und verwandte Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| CA2325781A1 (fr) | Nouveaux composes aminopyrroline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| ATE122892T1 (de) | Zusammensetzung gegen katarakt. | |
| CA2231026A1 (fr) | Nouveaux derives de benzenesulfonylamine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| KR890011593A (ko) | 쇼크 치료에 사용하기 위한 2-(페닐아미노)이미디졸린-(2)의 용도 |